hypotrichosis
Information
- Disease name
- hypotrichosis
- Disease ID
- DOID:4535
- Description
- "A hair disease that is characterized by sparse hair on the scalp resulting from abnormal hair follicle development and has_material_basis_in mutations in proteins involved in hair growth, division or proliferation of cells within hair follicles." [url:http\://en.wikipedia.org/wiki/Hypotrichosis, url:http\://ghr.nlm.nih.gov/condition/autosomal-recessive-hypotrichosis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00907426 | Completed | Phase 3 | Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin | August 2009 | May 2011 |
| NCT00958035 | Completed | Phase 4 | Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis | November 2009 | August 2010 |
| NCT01200251 | Completed | Phase 3 | Study of Bimatoprost Gel on Eyelash Growth | February 2007 | December 2008 |
| NCT01387906 | Completed | Phase 4 | Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo | March 2011 | June 2012 |
| NCT01448525 | Completed | Phase 4 | Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence | October 2011 | April 2012 |
| NCT01891487 | Completed | Phase 4 | Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows | May 2013 | January 2015 |
| NCT05723198 | Recruiting | Phase 3 | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata | February 27, 2023 | August 2029 |
| NCT05790941 | Recruiting | Early Phase 1 | Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation | March 11, 2023 | June 30, 2023 |
- Disase is a (Disease Ontology)
- DOID:421
- Cross Reference ID (Disease Ontology)
- MESH:D007039
- Cross Reference ID (Disease Ontology)
- MIM:PS605389
- Cross Reference ID (Disease Ontology)
- ORDO:55654
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:53602002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0020678
- HPO alt_id (Human Phenotype Ontology)
- HP:0002551
- HPO alt_id (Human Phenotype Ontology)
- HP:0004525
- HPO alt_id (Human Phenotype Ontology)
- HP:0004874
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001006
- OMIM Phenotype Series Number (OMIM)
- PS605389
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007039